Neurocrine Biosciences Shares Outstanding 2006-2019 | NBIX

Neurocrine Biosciences shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Neurocrine Biosciences shares outstanding for the quarter ending March 31, 2019 were 0.091B, a 1.71% increase year-over-year.
  • Neurocrine Biosciences 2018 shares outstanding were 0.095B, a 8.28% increase from 2017.
  • Neurocrine Biosciences 2017 shares outstanding were 0.088B, a 1.59% increase from 2016.
  • Neurocrine Biosciences 2016 shares outstanding were 0.087B, a 2.62% increase from 2015.
Neurocrine Biosciences Annual Shares Outstanding
(Millions of Shares)
2018 95
2017 88
2016 87
2015 84
2014 75
2013 67
2012 67
2011 56
2010 53
2009 39
2008 38
2007 38
2006 38
2005 37
Neurocrine Biosciences Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 91
Q4 2018 95
Q3 2018 97
Q2 2018 90
Q1 2018 90
Q4 2017 88
Q3 2017 88
Q2 2017 88
Q1 2017 87
Q4 2016 87
Q3 2016 87
Q2 2016 87
Q1 2016 86
Q4 2015 84
Q3 2015 86
Q2 2015 86
Q1 2015 80
Q4 2014 75
Q3 2014 76
Q2 2014 76
Q1 2014 70
Q4 2013 67
Q3 2013 67
Q2 2013 67
Q1 2013 67
Q4 2012 67
Q3 2012 66
Q2 2012 66
Q1 2012 63
Q4 2011 56
Q3 2011 56
Q2 2011 56
Q1 2011 56
Q4 2010 53
Q3 2010 56
Q2 2010 55
Q1 2010 47
Q4 2009 39
Q3 2009 39
Q2 2009 39
Q1 2009 39
Q4 2008 38
Q3 2008 38
Q2 2008 38
Q1 2008 38
Q4 2007 38
Q3 2007 38
Q2 2007 38
Q1 2007 38
Q4 2006 38
Q3 2006 38
Q2 2006 38
Q1 2006 37
Q4 2005 37
Q3 2005 38
Q2 2005 37
Q1 2005 37
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.661B $0.451B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.030B 33.88
Takeda Pharmaceutical (TAK) Japan $26.701B 7.84
Grifols (GRFS) Spain $13.249B 16.76
Sage Therapeutics (SAGE) United States $8.913B 0.00
Ionis Pharmaceuticals (IONS) United States $8.713B 19.05
Jazz Pharmaceuticals (JAZZ) Ireland $7.390B 10.13
Catalent (CTLT) United States $7.241B 29.06
Nektar Therapeutics (NKTR) United States $5.822B 9.49
Tilray (TLRY) Canada $3.793B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.518B 12.34
FibroGen (FGEN) United States $3.505B 0.00
United Therapeutics (UTHR) United States $3.427B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.448B 368.86
PTC Therapeutics (PTCT) United States $2.338B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.052B 7.39
Pacira Pharmaceuticals (PCRX) United States $1.803B 87.32
Xencor (XNCR) United States $1.764B 48.17
Portola Pharmaceuticals (PTLA) United States $1.754B 0.00
USANA Health Sciences (USNA) United States $1.738B 15.10
Tricida (TCDA) United States $1.694B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.688B 23.07
Zogenix (ZGNX) United States $1.661B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.604B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.504B 0.00
Aerie Pharmaceuticals (AERI) United States $1.457B 0.00
Heron Therapeutics (HRTX) United States $1.398B 0.00
Esperion Therapeutics (ESPR) United States $1.324B 0.00
Turning Point Therapeutics (TPTX) United States $1.245B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
Radius Health (RDUS) United States $1.014B 0.00
Endo (ENDP) Ireland $0.916B 1.47
ArQule (ARQL) United States $0.896B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.895B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.834B 0.00
CannTrust Holdings (CTST) Canada $0.683B 0.00
Organogenesis Holdings (ORGO) United States $0.669B 0.00
Odonate Therapeutics (ODT) United States $0.669B 0.00
Aptorum Group (APM) China $0.649B 0.00
TherapeuticsMD (TXMD) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.562B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.521B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Dermira (DERM) United States $0.506B 0.00
ChemoCentryx (CCXI) United States $0.484B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
GlycoMimetics (GLYC) United States $0.483B 0.00
Siga Technologies (SIGA) United States $0.443B 1.04
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Flexion Therapeutics (FLXN) United States $0.414B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 20.65
Collegium Pharmaceutical (COLL) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.391B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.374B 0.00
Karyopharm Therapeutics (KPTI) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 0.00
KalVista Pharmaceuticals (KALV) United States $0.343B 0.00
Forty Seven (FTSV) United States $0.331B 0.00
TCR2 Therapeutics (TCRR) United States $0.327B 0.00
Rafael Holdings (RFL) United States $0.306B 0.00
CASI Pharmaceuticals (CASI) United States $0.301B 0.00
ImmunoGen (IMGN) United States $0.296B 0.00
Harpoon Therapeutics (HARP) United States $0.290B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
OptiNose (OPTN) United States $0.285B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.263B 0.00
Molecular Templates (MTEM) United States $0.262B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Concert Pharmaceuticals (CNCE) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.240B 0.00
Aratana Therapeutics (PETX) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.205B 1.99
Calithera Biosciences (CALA) United States $0.204B 0.00
Recro Pharma (REPH) United States $0.201B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
IMV INC (IMV) Canada $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 57.31
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.175B 0.00
MEI Pharma (MEIP) United States $0.175B 0.00
Minerva Neurosciences (NERV) United States $0.172B 0.00
Galectin Therapeutics (GALT) United States $0.168B 0.00
Ardelyx (ARDX) United States $0.167B 0.00
Opexa Therapeutics (ACER) United States $0.166B 0.00
Bio Blast Pharma (ENLV) Israel $0.164B 0.00
Redhill Biopharma (RDHL) Israel $0.158B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.146B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Majesco Entertainment (PTE) United States $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.119B 0.00
Tyme Technologies (TYME) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.114B 0.00
AgeX Therapeutics (AGE) United States $0.111B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Champions Oncology (CSBR) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 69.44
Natural Alternatives (NAII) United States $0.092B 9.15
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.089B 0.00
Mast Therapeutics (SVRA) United States $0.088B 0.00
Cardiome Pharma (CORV) Canada $0.088B 0.00
Capnia (SLNO) United States $0.087B 0.00
DURECT (DRRX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.074B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.051B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
Lipocine (LPCN) United States $0.040B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.037B 0.00
PharmAthene (ALT) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
IsoRay (ISR) United States $0.030B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.027B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.38
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.82
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00